Abstract
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Highlights
Summary of results We observed a statistically significant decrease in serum phosphate levels in the three different cardiovascular risk (CVR) groups
Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients
This study was performed to determine whether serum phosphate levels are associated with increased risk for cardiovascular events
Summary
From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 7-11 November 2010. From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. Purpose of the study Hypophosphatemia may contribute directly to the development of obesity, hypertension and dyslipidemia. Hyperglycemia, insulin resistance, hyperlipidemia and hypertension, which are components of metabolic syndrome, are recognized as strong risk factors for cardiovascular disease [1]. This study was performed to determine whether serum phosphate levels are associated with increased risk for cardiovascular events
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
